Recurrent Pregnancy Loss: Clinical Trials

11 trials for Recurrent Pregnancy Loss, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 4 unknown, 1 recruiting, 1 suspended. 11 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 211Completed 4, Unknown 4, Recruiting 1, Suspended 1, Withdrawn 1
Phase 11Unknown 1
Phase 31Unknown 1

Follow Recurrent Pregnancy Loss: new trials by email Literature Review of Recurrent Pregnancy Loss trials Research Report on Recurrent Pregnancy Loss

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Recombinant Human G-CSF in Women With Unexplained Recurrent Miscarriage
Placebo control, Recombinant G-CSF - Recurrent Pregnancy Loss, Recurrent Miscarriages
Phase 2RecruitingFakih IVF Fertility Center1502026-07-102026-07-24
Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells
Mesenchymal stem cells capable of differentiation in the endometrial-decidual direction, Standard treatment according to the clinical protocols - Recurrent Pregnancy Loss
Phase 1 / Phase 2UnknownInstitute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus202022-11-012022-08-29
Intravenous Immunoglobulin and Prednisolone for RPL After ART.
Human Intravenous Immunoglobulins, (Privigen (R), CLS Behring), Prednisolone Tablets, Human Albumin Solution - Habitual Abortion, Recurrent Pregnancy Loss
Phase 2CompletedAalborg University Hospital802021-01-282025-11-24
Effect of Sildenafil Citrate on Mid Luteal Phase Uterine Artery Blood Flow in Patients With Recurrent Pregnancy Loss
Sildenafil 25Mg Tablet, Placebo Oral Tablet - Recurrent Pregnancy Loss
Phase 2CompletedAin Shams University802018-09-052021-01-22
Assessing the Endometrial Environment in Recurrent Pregnancy Loss and Unexplained Infertility
Uterine ERA and microbiome testing, Oral antibiotics and vaginal probiotics - Recurrent Pregnancy Loss, Unexplained Infertility
Phase 2CompletedStanford University412017-08-012025-04-01
Immunomodulatory Effects of IVIg on Pregnancy Rate of Patient With Recurrent Pregnancy Loss
IVIg - Recurrent Pregnancy Loss
Phase 2CompletedTabriz University of Medical Sciences502016-09-202018-09-17
Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss
Hydroxychloroquine (HCQ), Placebo - Recurrent Pregnancy Loss, Miscarriage
Phase 2WithdrawnUniversity of Utah2016-07-012016-08-12
A Multi-center, Placebo-controlled Study to Evaluate NT100 in Pregnant Women With a History of Unexplained Recurrent Pregnancy Loss (RPL)
NT100, Placebo - Recurrent Pregnancy Loss, Recurrent Miscarriage
Phase 2UnknownNora Therapeutics, Inc.1502014-06-012015-07-15
Comparison of Standard ART Practice vs. Trophectoderm Biopsy and Whole Chromosome Analysis
Next Generation Sequencing after Blastocyst biopsy - Infertility, Recurrent Pregnancy Loss
Phase 2UnknownReprogenetics2402013-09-012014-09-09
Preimplantation Genetic Diagnosis Using Blastocyst Biopsy and Array CGH
PGD - Infertility, Recurrent Pregnancy Loss
Phase 2SuspendedReprogenetics2002012-03-012013-08-21
Aspirin Versus Clopidogrel Effect on Uterine Blood Flow in Women With Unexplained Recurrent Miscarriages
Aspirin, Clopidogrel - Recurrent Pregnancy Loss
Phase 2 / Phase 3UnknownAin Shams University322012-03-012017-03-10

Narrower conditions

Abortion, Spontaneous (6)  ·  Abortion, Habitual (3)  ·  Infertility (2)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (6)  ·  Pregnancy Complications (6)  ·  Urogenital Diseases (6)  ·  Genital Diseases (2)

Interventions

Immunoglobulins, Intravenous (2)  ·  Anti-Bacterial Agents (1)  ·  Aspirin (1)  ·  Clopidogrel (1)  ·  Hydroxychloroquine (1)  ·  Prednisolone (1)  ·  Prostaglandins D (1)  ·  Sildenafil Citrate (1)  ·  Tablets (1)

Sponsors

Ain Shams University (2)  ·  Reprogenetics (2)  ·  Aalborg University Hospital (1)  ·  Fakih IVF Fertility Center (1)  ·  Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus (1)  ·  Nora Therapeutics, Inc. (1)  ·  Stanford University (1)  ·  Tabriz University of Medical Sciences (1)  ·  University of Utah (1)

Countries

United States (4)  ·  Egypt (2)  ·  Belarus (1)  ·  Denmark (1)  ·  Iran (1)  ·  United Arab Emirates (1)  ·  United Kingdom (1)

Top investigators

Santiago Munne, PhD (2)  ·  Andrei Hancharou, Dr (1)  ·  Mehdi Yousefi, Immunologist (1)  ·  Mohamed I Ellaithy, M.D. (1)  ·  Mohammad Nouri, Ph.D (1)  ·  Ole B Christiansen (1)  ·  Robert Silver, MD (1)

Results publications

PMID 12765346, PMID 17166218, PMID 19710204, PMID 19819893, PMID 21095154, PMID 22889462, PMID 24628478, PMID 30776296, PMID 32898291, PMID 36137638, PMID 41263919